PRIME POLICY GROUP

Lobbying for KEDRION BIOPHARMA · Production of Plasma-Derived Therapies

Filing · LD-1 registration Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Lobbying activity 1

Pharmaceutical Tariffs

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.